Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.

Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, Lundgren J.

AIDS. 2011 Mar 27;25(6):843-50. doi: 10.1097/QAD.0b013e328344037a.

PMID:
21192233
2.

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, Wood R.

Antivir Ther. 2007;12(1):83-8.

PMID:
17503751
3.

Antiretroviral therapy programmes in resource limited settings.

del Rio C, Armstrong W.

BMJ. 2011 Nov 9;343:d6853. doi: 10.1136/bmj.d6853. No abstract available.

PMID:
22074712
4.

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

Bishai D, Colchero A, Durack DT.

AIDS. 2007 Jun 19;21(10):1333-40.

PMID:
17545710
5.

Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.

Schneider K, Puthanakit T, Kerr S, Law MG, Cooper DA, Donovan B, Phanuphak N, Sirisanthana V, Ananworanich J, Ohata J, Wilson DP.

AIDS. 2011 Jun 1;25(9):1143-51. doi: 10.1097/QAD.0b013e3283466fab.

PMID:
21505319
6.

Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.

Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr WM, Nash D, Abrams EJ; MTCT-Plus Initiative.

AIDS. 2010 Feb 20;24(4):515-24. doi: 10.1097/QAD.0b013e3283350ecd.

PMID:
19996939
7.

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, Doro Altan A, Zimba Ida V, San Lio MM, De Luca A; DREAM Program.

Clin Infect Dis. 2009 Jan 1;48(1):115-122.

PMID:
20380075
8.

Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.

Kumarasamy N, Krishnan S.

Curr Opin HIV AIDS. 2013 Nov;8(6):586-90. doi: 10.1097/COH.0000000000000004. Review.

PMID:
24100872
9.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
10.

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.

van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC.

Trop Med Int Health. 2009 Aug;14(8):856-61. doi: 10.1111/j.1365-3156.2009.02309.x. Epub 2009 Jun 22.

11.

Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.

Kitkungvan D, Apisarnthanarak A, Laowansiri P, Mundy LM.

HIV Med. 2008 Oct;9(8):636-41. doi: 10.1111/j.1468-1293.2008.00611.x. Epub 2008 Jul 17.

12.

Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.

Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N, Hogg RS, Cooper C.

AIDS. 2011 Mar 27;25(6):851-5. doi: 10.1097/QAD.0b013e32834564e9.

PMID:
21330903
13.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
14.

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.

PMID:
19474468
15.

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.

Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1443-51. doi: 10.1016/S0140-6736(08)60624-8.

PMID:
18440426
16.

Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.

Bélec L, Bonn JP.

Future Microbiol. 2011 Nov;6(11):1251-60. doi: 10.2217/fmb.11.121. Review.

PMID:
22082287
17.

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.

Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. German.

PMID:
17457780
18.

Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.

Palacios R, Senise J, Vaz M, Diaz R, Castelo A.

HIV Med. 2009 Mar;10(3):157-62. doi: 10.1111/j.1468-1293.2008.00665.x.

19.

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.

Murillo W, de Rivera IL, Parham L, Jovel E, Palou E, Karlsson AC, Albert J.

HIV Med. 2010 Feb;11(2):95-103. doi: 10.1111/j.1468-1293.2009.00747.x. Epub 2009 Aug 3.

20.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].

Panel de expertos de GESIDA; Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53. Spanish.

PMID:
17261244

Supplemental Content

Support Center